Philip Morris
Passive Smoking in Females and Coronary Heart Disease
Fields
- Author
- Cheng, X.L.
- Fong, C.C.
- He, Y.
- Li, L.S.
- Li, L.X.
- Qua, Q.L.
- Fong, C.C.
- Type
- PSCI, PUBLICATION SCIENTIFIC
- ABST, ABSTRACT
- CHAR, CHART, GRAPH, TABLE, MAPS
- ABST, ABSTRACT
- Document File
- 2023511660/2023512308/Ets: Heart Disease 930900
- Site
- R529
- Author (Organization)
- Inst of Infectious Diseases
- Xian Medical College
- Master ID
- 2023511661/2307
Related Documents:- 2023511661-2307 Environmental Tobacco Smoke and Heart Disease
- 2023511710 the Relationship of Passive Smoking to Various Health Outcomes Among Seventh-Day Adventists in California.
- 2023511714-1718 Passive Smoking and the Risk of Heart Attack or Coronary Death
- 2023511722-1727 Effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers A Prospective Study
- 2023511728 Erratum
- 2023511729 'effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers: A Prospective Study'
- 2023511730 the First Author Replies
- 2023511734-1737
- 2023511749-1756 Original Contributions Heart Disease Mortality in Nonsmokers Living with Smokers
- 2023511760-1781 Lung Cancer in Japan: Effects of Nutrition and Passive Smoking
- 2023511785-1789 Passive Smoking and Cardiorespiratory Health in A General Population in the West of Scotland
- 2023511790 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511791-1792 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511793-1795 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511800-1802 Public Health Briefs Passive Smoking and 20-Year Cardiovascular Disease Mortality Among Nonsmoking Wives, Evans County, Georgia
- 2023511806-1816 Relationship of Passive Smoking to Risk of Lung Cancer and Other Smoking-Associated Diseases
- 2023511818 Increased Incidence of Heart Attacks in Nonsmoking Women Married to Smokers
- 2023511822-1824 Cvd Epidemiology Newsletter
- 2023511829-1841 Original Contributions Effects of Passive Smoking in the Multiple Risk Factor Intervention Trial
- 2023511842 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511843-1844 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511845 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511846 the Authors Reply
- 2023511849-1853 Smoking As A Risk Factor for Cerebral Ischemia
- 2023511857-1862 Urinary Cotinine Measurement in Patients with Buerger's Disease - Effects of Active and Passive Smoking on the Disease Process
- 2023511865-1881 An Estimate of Adult Mortality in the United States From Passive Smoking
- 2023511882 Editorial Cardiovascular Risks of Environmental Tobacco Smoke
- 2023511883-1887 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511888-1890 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511891-1892 Ischemic Heart Disease: Response to Lee
- 2023511893-1895 Rebuttal to Lee / Katzenstein Commentary on Passive Smoking Risk
- 2023511896-1899 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511900-1906 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response to Criticism
- 2023511908-1911 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511912 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511913 Passive Smoking in New Zealand
- 2023511914 Passive Smoking in New Zealand
- 2023511915 Passive Smoking in New Zealand
- 2023511916 Passive Smoking and Passive Thinking
- 2023511918-1937 Cardiovascular Diseases and the Work Environment A Critical Review of the Epidemiological Literature on Chemical Factors
- 2023511939-1950 Clinical Progress Series Passive Smoking and Heart Disease Epidemiology, Physiology, and Biochemistry
- 2023511952-1957 Review Passive Smoking and the Risk of Heart Disease
- 2023511958-1961 Aha Medical / Scientific Statement Position Statement Environmental Tobacco Smoke and Cardiovascular Disease A Position Paper From the Council on Cardiopulmonary and Critical Care, American Heart Association
- 2023511965-1983 the Health Consequences of Involuntary Smoking A Report of the Surgeon General
- 2023511985-1998 Environmental Tobacco Smoke Measuring Exposures and Assessing Health Effects
- 2023512000-2015 Environmental Tobacco Smoke Proceedings of the International Symposium at Mcgill University 890000 Environmental Tobacco Smoke and Cardiovascular Disease: A Critique of the Epidemiological Literature and Recommendations for Future Research
- 2023512016-2028 Panel Discussion on Cardiovascular Disease
- 2023512030-2037 Indoor Air Quality and Ventilation Environmental Tobacco Smoke (Ets) and Cardiovascular Disease
- 2023512039-2054 A Critique of the Methods Used to Assess the Toxic Effects on Man of Combustion Products.
- 2023512056-2066 Coronary Heart Disease and Involuntary Smoking
- 2023512068-2077 7. Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512079-2088 Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512090-2091 Editorial Give A Dog-End A Bad Name
- 2023512093-2108 Weaknesses in Recent Risk Assessments of Environmental Tobacco Smoke
- 2023512110-2129 Environmental Tobacco Smoke and Mortality A Detailed Review of Epidemiological Evidence Relating Environmental Tobacco Smoke to the Risk of Cancer, Heart Disease and Other Causes of Death in Adults Who Have Never Smoked - 5 Heart Disease
- 2023512131-2155 Environmental Tobacco Smoke Exposure and Occupational Heart Disease
- 2023512157-2171 Passive Smoking and Coronary Artery Disease. Biological Plausibility and Severity of Effect
- 2023512173-2180 Carbon Monoxide and Cardiovascular Disease: An Analysis of the Weight of Evidence
- 2023512185-2189 the Effects of Passive Inhalation of Cigarette Smoke on Excercise Performance
- 2023512192-2195 Effect of Passive Smoking on Angina Pectoris
- 2023512199-2202
- 2023512203-2213 Effect of 'passive' Smoking on the Physical Load Tolerance of Coronary Heart Disease Patients
- 2023512216-2220 Indoor Passive Smoking: Its Effect on Cardiac Performance
- 2023512223-2224 Passive Smoking Severely Decreases Platelet Sensitivity to Antiaggregatory Prostaglandins
- 2023512227-2230 Platelet Sensitivity to Prostacyclin in Smokers and Non-Smokers
- 2023512233-2237 Besitzen Passivraucher Ein Erhohtes Thromboserisiko?
- 2023512241-2244 Passive Smoking Affects Endothelium and Platelets
- 2023512247-2253 Lipoprotein and Oxygen Transport Alterations in Passive Smoking Preadolescent Children the Mcv Twin Study
- 2023512256-2257 Abstracts of the 30th Annual Conference on Cardiovascular Disease Epidemiology Children's Hdl-Chol: the Effects of Tobacco: Smoking, Smokeless and Parental Smoking
- 2023512261-2266 Passive Smoking Alters Lipid Profiles in Adolescents
- 2023512269-2274 Serum Lipids & Lipoprotein Profiles of Cigarette Smokers & Passive Smokers
- 2023512278-2279 8th Worldconference on Tobacco or Health Building A Tobacco-Free World 920330 - 920403 Buenos Aires - Argentina Abstracts, Posters and Videos. Serum Lipoproteins in Nonsmokers Chronically Exposed to Tobacco Smoke in the Workplace
- 2023512282 the Association Between Carotid Arterial Wall Thickness and Active and Passive Cigarette Smoking
- 2023512285 Passive Smoking and Carotid Artery Wall Thickness: the Aric Study
- 2023512290-2297 Passive Smoking Increases Experimental Atherosclerosis in Cholesterol-Fed Rabbits
- 2023512300-2301 Supplement to Circulation Abstracts From the 65th Scientific Sessions New Orleans Convention Center New Orleans, Louisiana 921116 - 921119
- 2023512304-2307 Association of Passive Smoking with Increased Coronary Heart Disease Risk Is Not Explained by Elevation of Leucocyte Count
- Litigation
- Okag/Privilege Withdrawn
- Okag/Produced
- Characteristic
- EXTR, EXTRA
- MARG, MARGINALIA
- TRSL, TRANSLATION
- MARG, MARGINALIA
- Area
- SCIENTIFIC AFFAIRS/BLACK LATERAL OLD S&T
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- ahc02a00
Document Images
lL v% GZrtI t, -C.( . L YA-v, c`'o.-L iow
Passive saokinq in 7emales and Coronary Seart Disease
Dy Y. He, L.X.Li, C.C. Fong, Znatitute of Infectious Diseases,
and L.S. Li, X.L. Chang, Q.L. Qua, Department of Cardioloqy and
Internal M®dicina, Xian Medical College.
ADBTRACT
Thirty four cases of women with coronary heart disease (CHD)
(22 cases diagnosed by coronary arterioqraphy, and 12 cases
diagnosed as havinq myocardial infarction) were used in an
investigation designed to assess the association between passive
smokinq in women and the establishment of CxD. The odds ratio (OR)
ot non-smoking women developing CHD as a result of exposure to
passive smoke is 3.0-3.5 (p<0.05). A dose response relationship
was detected between the number of'passive smoke exposure years and'
the increase in OR for CHD. Multiple regression analysis shows
that of the many risk factors for CHD, passive smoke exposure is
significantly correlated with CHD. Women exposed to passive smoke
also showed abnormal levels of serum LDL-C, HDL-C, apoAl and apoB,
xey words
Coronary heart disease, coronary arteriography, passive smoke
Experimental investigations have demonstrated that the
chemical constituents generated in the sidestream smoke often
contain the same harmful chemicals as in mainstream smoke inhaled
by smokers, and that there is considerable adverse otfects
contributed by sidestream smoke to non-smokars who are passively
exposad.'-= A number of reports have appeared showing a correlation
between passive smoke and the damage to lunq l~unctions, increased
incidence of lung cancer, and angina pectoris."6 A limited number
of investigations have bean focused on the subject of passive smoke
in the Paople's Republic of China, and have only concentrated on
studyinq the influence of passive smokinq on lung functions.7 ' In
this communication we report the relationship between passive smoke
exposura and female patients who were hospitalized because of
coronary heart disease.

t
Yatsrials aaa xethods
6ubjects consisted of patients hospitalized betwesn 19flS-1987
and diagnosed as having coronary heart dlsease and myocardial
infarction. They were matched employing the ls2 method as follows:
those who were admitted because of possible coronary heart disease
and were later confirmed by coronary arteriography to be normals;
patients with endocrine dysfunctions but free of CHDs; and people
randomly selected from the population. Thus three groups were
included in the present investigation: Group 1, thoss hospitalized
and diagnosed with Cf3IDs or myocardial infarction; Group 2, those
hospitalized with endocrine problems but having no symptoms of
CaDs, and Group 3, normals from the general population.
Each of the subjects in the thres groups was interviewed using
a standardized questionnaire. Some of the questions addressed
included : subjects and the spouses smoking history, ths age at
which smoking began, the average daily cigarette consumption.
Active and passive smoking were dafined as follows : 1. Smoking at
least one cigarette per day for a period of at least one year. The
spouse is dofined as an ax-smoker if he has already stopped smoking
at least 5 years at the time of interview. 2. Wife who is a non-
smokar but has lived with a smoking husband for at least 5 years is
classified as a passive smoker. 3. If husband is a smoker before
marriage, the wife exposure begins at time of marriage.
Alternatively, the wife can become exposed after marriage if the
husband picks up the smoking habit after marriage. Total exposure
time is determined by divorce, death of husband, or when the
husband quits smoking and becomes an ex-smokQr. 4. Single female is
considered to be equivalent to a female without a smoking spouse.
To verify the accuracy of the data collected by the structured
interview, tape recording was used and randomized re-interview was
performed.
Subject group consist of 34 casas (22 cases diagnosed with
CHD, and 12 cases diagnosed with myocardial infarction). Control
group consist of 34 hospitalized subjects (with 13 suspectsd of
CHDa but later confirmed to be normals) and 34 randomly selected
matched for race, occupation, residence and age (+/- 5 years).
Multipla regressional analysis was performed and the data analyzed
suing a 8un-68000 electronic calculator.9
Results
i. Coaparison betrssa the *vDject and the Comtrol Qroups
No significant differences exist between the two groups in
regard to age, education, the marriaqe age. The mean ages of the
diseased and control groups are 53.714.28 and 52.9315.24,
respectively (t-2.282, ps0.05)

2. Effeats of tassive 4moxing
Table 1 shows a comparison between disease and paired control
groups. The OR of qetting CHD for nonsmoking women living with a
smoking husband is 3.0:0, with a 95% CI of 1.256-7.168, i.e. the
risk of women gsttinq C'HD is 3 times higher for those with husbands
that smoke compared to those with nonsmokers husbands.
Diseased +
Group -
Table 1. A comparison of Passive Smoking Status
in Diseased and Control Groups
Control Group
+ +
+ - -
4 12 9
3 4
3.00
1.256-7.168
6.117 (c 0.05)
A. Dose Response Relationship
Table 2 illustrates the association between husbandsr average
daily cigarette consunption, passive smoke, exposure years,
cumulative passive smoke amount index, and the ORe of getting CHD.
There is a noticaabls mose response relationship, i.e. ac the
amount of passive smoke exposure increasss, ths risk of getting CHD
also becomes greater.
Table 2. Dosa Response Relationship between
Passive smoke Exposure and CHDs
Subject Control OR X2
N
O
Kusbands daily N
cigarette consumption G?
Git
0 9 38 1.000 ..... }.i
~
.1~
45

<20 12 22 2.303 1.8B0
>20 13 8 6.661 10.09B**
Passive Smoke
Exposure Years
0
9
36
1.000
.....
510~ 4 9 1.877 0.266
$20 6 11 3.071 2.581
>20 13 10 5.489 8.230**
Cumulative Passive
Smoke index (Years)
0
9
38
1.000
.....
1-199 4 11 1.535 0.066
200-399 6 11 2.303 1.009
400-599 6 5 5.067 4.054'
600' 9 3 12.667 11.35a~"
p<o.05 p<a.01
B. Association with Clinical Diagnosis
in the patients group, 21 cases were diagnosed with, angina
poctoris and 13 cases with myocardial infarction. The number of
passive smokars in both clinical settings is similar (X= - 1.298,
p>0.5). Thsss results are illuctratnd in Table 3. The results
show that angina poctoris is clearly and significantly correlated
with passive smoking. Although myocardial infarction in the
passive smoking group show an OR of greater than 1, it did not
reach statistical significance, which may be related to the small
sample size.

Table 3. Clinical Diagnosis in Passive Smoke Group
Exposure to Passive Smoke Exposure to Passive Smoke
Yes No Yes No
Anq na Psctorxo Myocard,& -"n arct on
Subject Group 17 ~ 8 5
Control Group 20 22 10 16
-OR 4.In 2. 550
X= 5.035 1.018
P c0.05 >0.05
C. n2ood cholesterol and Lipoprotein Level Changes in
Passive Smokers
By controlling for age, weight, and other risk factors, a
decrease in serum HDL-C and apoAl isvel was found in passive
smokers, whereas LDL-C, apoB and apo B/Al levels are higher than
those not exposed to passive smoke. Tha level of HDL-C, apoAi and
apoB/Al levels are significantly different between the subject and
control groups (Table 4)

Table 4. 8lood Cholesterol and Serum Lipoprotain Levels
in Female Passive Smokers
Control Group CHD Group
Non-txposed Eacposed Non-axposed Exposed
Number 26 20 9 24
Total
cholastarol
(mmol/L) 4.42t0,6s
4.47±0.68
5.15t0.e6
5.80t0.73*
LDL (mmol[L)2.34t0.68 2.5210.68 3.3510.86 3.85±0.71
HDL (mnol/L)1.41t0.18 1.Z9t0.18* 1.2610.21 1.12t0.17*
LDL/HDL 1.74±0.51 1.98±0.60 2.75±0.79 3.42t0,.74rt
apoAi (q/L) 1.27f0.24 1.1110.23* 0.95t0.18 0.81t0.13*
apoB (q/L) 0.7110.17 0.7410.14 1.0320.17 1.1610.20
apoB/apoA1 0.61t0.19 0.67t0.22 1.2110.40 1.36t0.22*
*Pc0.05, P values re er to compar-ison-,ba-tvQen non-exposed and
exposed cases.
3. xultipis Loqistia ReqrOssion Analysis
Srven risk factors believed to contribute to CHD were
subjacted to logistic regression analysis. These factors include:
history of hypertsnsion (xi}, lamily history of hypertension (x2),
lamily history of CHD (x3), history of passive smoke exposure (x4),
history of drinking (x5), exercise per.formanee test (x6) and
history of hypercholsstersmia (x7). The results are shown Sn Table
S.
Table 5. Multipls Regression Analysis of CHD Risk Factors
Hi Var(ni) 6(Bi) t2'D(si) OR G P ~
History or ~
Passive smoka 0.406 0.069 0.083 4.87 1.5004 16.93 <0~.01 ~
History of I-a
Hypertension 0.714 0.052 0.227 3.147 2.0429 8.90 <0.01~A
_j

DSSCIIassaN
To avoid and minimize bias introduced in studies using
hospitalized subjacts, the present investigations compared the
subjects groups to two control groups, one group consisting of
patients hospitalized for reasons other than CHDs, and a second
group randomly selected from the general population. Thaze two
control groups are compared to the CHD-diseasad group.
Investigations on the effacts of passive smoking in females
are more difficult to perform than comparable studies aimed at the
effects of active smoking, because the effects of passive smoking
may be dependent on such factors as humidity, ventilation and other
indoor environmental considerations. Studies to date have not been
ab2e to produce a widely accepted standardized protocol for this
type of investigation. One of the methods which have been used to
assess passive smoke exposure in females relies upon the smoking
status of spousesfl`~~hich have been used in sevaral previous
published reports. The method appears to provide a eartain
degree of simplicity, feasibility, and relative objeetivity.,
lamale passive smokars have an OR of 3-3.5 in getting CHD,
with 95% CI greater than 1. The exposure dose is associated with
angina pectoris, in agreement with results of other investigators.
The associations remain after adjusting for potential confounder6,
suggesting that there is a direct correlation between passive
smoking and CHD in females. Additionally, our invaFtigationa also
showed alterations in blood cholesterol and lipoprotein levels,
indicating that an alteration in the metabolism of cholesterol
and/or lipoprotein could contribute to CHD in female passive
smokers. According to Scott at al.1, 85= of indoor smoke is due to
sidestream smoke, which is known to contain a higher concentration
of many toxic chemicals than mainstream smoke, and presumably
exhibit a more pronounced adverse health effect. Previous studies
have shown that an increase in blood COHb levels capabl,e of
producing an obviously untoward effect in people with heart and
lung diseases.' Arrownow studied 10 subjecta with angina pectoris,
and reported a doubling of blood COHb 2 hours after exposure to
indoor tobacco smoke in a poorly ventilated environment. These
subjects also showed a 334 reduction in time of exarcise before
reachi'ng a perceived exertion. The mechanism, however, remains to
be investigated.
In peoplets Republic of China, 33.884 of population aqQ>15
years are smokers and 614 of yaales regular smokers. The indirect
public health eoneequencas of smoxinq has not received enough
attention. Despite the limited number of easeo used in the present investigation which obviously
have sevare restrictions, it suggests
that passive smoking is related to CKD in females. Thus, smoking
in public should be restricted ~
'CA
~
